Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2013 | 1 |
2014 | 2 |
2018 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
Vasoactive peptides and the pathogenesis of pulmonary hypertension: role and potential therapeutic application.
Handb Exp Pharmacol. 2013;218:477-511. doi: 10.1007/978-3-642-38664-0_19.
Handb Exp Pharmacol. 2013.
PMID: 24092352
Review.
Phosphodiesterase 2 inhibition preferentially promotes NO/guanylyl cyclase/cGMP signaling to reverse the development of heart failure.
Baliga RS, Preedy MEJ, Dukinfield MS, Chu SM, Aubdool AA, Bubb KJ, Moyes AJ, Tones MA, Hobbs AJ.
Baliga RS, et al.
Proc Natl Acad Sci U S A. 2018 Jul 31;115(31):E7428-E7437. doi: 10.1073/pnas.1800996115. Epub 2018 Jul 16.
Proc Natl Acad Sci U S A. 2018.
PMID: 30012589
Free PMC article.
Item in Clipboard
Intrinsic defence capacity and therapeutic potential of natriuretic peptides in pulmonary hypertension associated with lung fibrosis.
Baliga RS, Scotton CJ, Trinder SL, Chambers RC, MacAllister RJ, Hobbs AJ.
Baliga RS, et al.
Br J Pharmacol. 2014 Jul;171(14):3463-75. doi: 10.1111/bph.12694.
Br J Pharmacol. 2014.
PMID: 24641440
Free PMC article.
Item in Clipboard
Inhibition of phosphodiesterase 2 augments cGMP and cAMP signaling to ameliorate pulmonary hypertension.
Bubb KJ, Trinder SL, Baliga RS, Patel J, Clapp LH, MacAllister RJ, Hobbs AJ.
Bubb KJ, et al.
Circulation. 2014 Aug 5;130(6):496-507. doi: 10.1161/CIRCULATIONAHA.114.009751. Epub 2014 Jun 4.
Circulation. 2014.
PMID: 24899690
Free PMC article.
Item in Clipboard
Cite
Cite